申请人:Liu Chunjian
公开号:US20090118272A1
公开(公告)日:2009-05-07
A compound of Formula (I)
an enantiomer, diastereomer or a pharmaceutically-acceptable salt thereof, wherein A is independently selected from:
further wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, and W are as described herein.
Also disclosed is a compound of Formula (II)
an enantiomer, diastereomer, or a pharmaceutically-acceptable salt thereof, wherein each of G, X and Y are independently CH or N, wherein at each occurrence at least one of G, X or Y is N and the other two of G, X or Y are CH; and B is independently selected from:
further wherein R
1
, R
2
, R
3
, R
4
, R
5
, R
8
, R
9
and Z are as described herein.
Also disclosed are pharmaceutical compositions containing compounds of Formula (I) and Formula (II), and methods of treating conditions associated with the activity of p38 kinase.
公式(I)的化合物,其对映异构体、顺反异构体或其药学上可接受的盐,其中A是独立选择的,包括:进一步,其中R1、R2、R3、R4、R5、R6、R7和W如此描述。还披露了公式(II)的化合物,其对映异构体、顺反异构体或其药学上可接受的盐,其中G、X和Y中的每个都是独立选择的CH或N,其中在每次出现时,至少有一个G、X或Y是N,而另外两个G、X或Y是CH;B是独立选择的,包括:进一步,其中R1、R2、R3、R4、R5、R8、R9和Z如此描述。还披露了包含公式(I)和公式(II)的化合物的制药组合物,以及治疗与p38激酶活性相关的疾病的方法。